Fructose metabolism in humans - what isotopic tracer studies tell us - PubMed (original) (raw)
Fructose metabolism in humans - what isotopic tracer studies tell us
Sam Z Sun et al. Nutr Metab (Lond). 2012.
Abstract
Fructose consumption and its implications on public health are currently under study. This work reviewed the metabolic fate of dietary fructose based on isotope tracer studies in humans. The mean oxidation rate of dietary fructose was 45.0% ± 10.7 (mean ± SD) in non-exercising subjects within 3-6 hours and 45.8% ± 7.3 in exercising subjects within 2-3 hours. When fructose was ingested together with glucose, the mean oxidation rate of the mixed sugars increased to 66.0% ± 8.2 in exercising subjects. The mean conversion rate from fructose to glucose was 41% ± 10.5 (mean ± SD) in 3-6 hours after ingestion. The conversion amount from fructose to glycogen remains to be further clarified. A small percentage of ingested fructose (<1%) appears to be directly converted to plasma TG. However, hyperlipidemic effects of larger amounts of fructose consumption are observed in studies using infused labeled acetate to quantify longer term de novo lipogenesis. While the mechanisms for the hyperlipidemic effect remain controversial, energy source shifting and lipid sparing may play a role in the effect, in addition to de novo lipogenesis. Finally, approximately a quarter of ingested fructose can be converted into lactate within a few of hours. The reviewed data provides a profile of how dietary fructose is utilized in humans.
Figures
Figure 1
Major metabolic pathways and flux of dietary glucose and fructose. P = phosphate. For enzymes numbered in circles: 1 = hexokinase/glucokinase or Glucose-6-phosphatase, 2 = phosphoglucose isomerase, 3 = hexokinase, 4 = fructokinase, 5 = glycogen synthase or phosphorylase, 6 = phosphofructokinase, 7 = aldolase, 8 = triose phosphate isomerase, 9 = triose kinase, 10 = several enzymes including pyruvate kinase, 11 = pyruvate dehydrogenase complex,12 = lactate dehydrogenase,13 = ketothiolase and other 3 enzymes,14 = enzyme group related to citric acid cycle, 15 = acetyl CoA carboxylase,16 = multienzyme complexes, 17 = acyl CoA synthase, 18 = glycerol-phosphate acyl transferase and triacylglycerol synthase complex. The dashed-line and arrow represents minor pathways or will not occur under a healthy condition or ordinary sugar consumption. The compound names in bold would be major metabolic intermediates or end products of glucose or fructose metabolism.
Figure 2
Dietary fructose and glucose oxidation (in normal subjects, mean + SD). On horizontal axis, ‘studies = number’ means that how many studies the bar data averaged from. In the Figure, 3–6 hours and 2–3 hours represent study monitoring period. The noted data variations between studies could be due to the differences of sugar dosages, tracer labeling forms, sugar administration methods, subject characteristics, and/or measurement errors. Also, the produced CO2 from labeled sugar oxidation can arise directly from sugar molecules themselves, or other compounds converted from the sugars, such as glucose, lactate, or fatty acid from fructose.
Figure 3
Metabolic fate of dietary fructose carbons. The data are obtained within study periods less than or equal to 6 hours. After 50–150 gm fructose ingestion, the peak of fructose concentration in plasma would be between 3–11 mg/dL. The percent data above arrow lines or under box are the estimated amounts of ingested fructose doses via the pathway, and the question mark represents that the data remain to be further confirmed. The dash-line represents presumably minor pathways.
Similar articles
- Fructose and metabolic health: governed by hepatic glycogen status?
Hengist A, Koumanov F, Gonzalez JT. Hengist A, et al. J Physiol. 2019 Jul;597(14):3573-3585. doi: 10.1113/JP277767. Epub 2019 Apr 21. J Physiol. 2019. PMID: 30950506 Free PMC article. Review. - Sex Differences in Hepatic De Novo Lipogenesis with Acute Fructose Feeding.
Low WS, Cornfield T, Charlton CA, Tomlinson JW, Hodson L. Low WS, et al. Nutrients. 2018 Sep 7;10(9):1263. doi: 10.3390/nu10091263. Nutrients. 2018. PMID: 30205493 Free PMC article. Clinical Trial. - The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.
Moore JB, Gunn PJ, Fielding BA. Moore JB, et al. Nutrients. 2014 Dec 10;6(12):5679-703. doi: 10.3390/nu6125679. Nutrients. 2014. PMID: 25514388 Free PMC article. Review. - Peripheral glucose appearance rate following fructose ingestion in normal subjects.
Nuttall FQ, Khan MA, Gannon MC. Nuttall FQ, et al. Metabolism. 2000 Dec;49(12):1565-71. doi: 10.1053/meta.2000.18553. Metabolism. 2000. PMID: 11145118 - Does fructose consumption contribute to non-alcoholic fatty liver disease?
Tappy L, Lê KA. Tappy L, et al. Clin Res Hepatol Gastroenterol. 2012 Dec;36(6):554-60. doi: 10.1016/j.clinre.2012.06.005. Epub 2012 Jul 12. Clin Res Hepatol Gastroenterol. 2012. PMID: 22795319 Review.
Cited by
- The Effects of Long-Term High Fat and/or High Sugar Feeding on Sources of Postprandial Hepatic Glycogen and Triglyceride Synthesis in Mice.
Reis-Costa A, Belew GD, Viegas I, Tavares LC, Meneses MJ, Patrício B, Gastaldelli A, Macedo MP, Jones JG. Reis-Costa A, et al. Nutrients. 2024 Jul 9;16(14):2186. doi: 10.3390/nu16142186. Nutrients. 2024. PMID: 39064628 Free PMC article. - Activation of AMPD2 drives metabolic dysregulation and liver disease in mice with hereditary fructose intolerance.
Andres-Hernando A, Orlicky DJ, Kuwabara M, Fini MA, Tolan DR, Johnson RJ, Lanaspa MA. Andres-Hernando A, et al. Commun Biol. 2024 Jul 11;7(1):849. doi: 10.1038/s42003-024-06539-1. Commun Biol. 2024. PMID: 38992061 Free PMC article. - Carbohydrate Ingestion before Exercise for Individuals with McArdle Disease: Survey Evidence of Implementation and Perception in Real-World Settings.
Torrens SL, Parr EB, McNulty C, Ross L, MacLaughlin H, Robergs RA. Torrens SL, et al. Nutrients. 2024 May 9;16(10):1423. doi: 10.3390/nu16101423. Nutrients. 2024. PMID: 38794661 Free PMC article. - Inflammatory response in dairy cows caused by heat stress and biological mechanisms for maintaining homeostasis.
Kim H, Jo JH, Lee HG, Park W, Lee HK, Park JE, Shin D. Kim H, et al. PLoS One. 2024 Mar 25;19(3):e0300719. doi: 10.1371/journal.pone.0300719. eCollection 2024. PLoS One. 2024. PMID: 38527055 Free PMC article. - Metabolic Effects of Selected Conventional and Alternative Sweeteners: A Narrative Review.
Teysseire F, Bordier V, Beglinger C, Wölnerhanssen BK, Meyer-Gerspach AC. Teysseire F, et al. Nutrients. 2024 Feb 23;16(5):622. doi: 10.3390/nu16050622. Nutrients. 2024. PMID: 38474749 Free PMC article. Review.
References
- USDA-ERS. Food Availability: Spreadsheets-Added sugar and sweeteners. 2010. http://wwwersusdagov/Data/FoodConsumption/FoodAvailSpreadsheetshtm#sweets.
- Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sanchez-Lozada LG. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr. 2007;86:899–906. - PubMed
- Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79:537–543. - PubMed
- Teff KL, Elliott SS, Tschop M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab. 2004;89:2963–2972. doi: 10.1210/jc.2003-031855. - DOI - PubMed
- Teff KL, Grudziak J, Townsend RR, Dunn TN, Grant RW, Adams SH, Keim NL, Cummings BP, Stanhope KL, Havel PJ. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab. 2009;94:1562–1569. doi: 10.1210/jc.2008-2192. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous